Use of percentage of free prostate-specific antigen to identify men at high risk of prostate cancer when psa levels are 2.51 to 4 ng/mL and digital rectal examination is not suspicious for prostate cancer: an alternative model

By Catalona W.J.   Partin A.W.   Finlay J.A.   Chan D.W.   Rittenhouse H.G.   Wolfert R.L.   Woodrum D.L.  

Urology, Vol. 54, Iss. 2, 1999-08 ,pp. : 220-224

Elsevier

Access to resources Recommend Favorite

Percentage of free prostate-specific antigen in sera predicts aggressiveness of prostate cancer a decade before diagnosis

By Carter H.B.   Partin A.W.   Luderer A.A.   Metter E.J.   Landis P.   Chan D.W.   Fozard J.L.   Pearson J.D.  

Urology, Vol. 49, Iss. 3, 1997-05 ,pp. : 379-384

Elsevier

Access to resources Recommend Favorite

Predictive factor analysis as the basis for the clinical utility of percent positive prostate biopsies in patients with intermediate-risk prostate cancer

By Yoon J.H.   Chen M.-H.   Renshaw A.A.   Richie J.P.   D'Amico A.V.  

Urology, Vol. 60, Iss. 3, 2002-09 ,pp. : 454-457

Elsevier

Access to resources Recommend Favorite

Follow-Up of Men with Elevated Prostate-Specific Antigen and One Set of Benign Biopsies at Prostate Cancer Screening

By Zackrisson B.   Aus G.   Lilja H.   Lodding P.   Pihl C.-G.   Hugosson J.  

European Urology, Vol. 43, Iss. 4, 2003-04 ,pp. : 327-332

Elsevier

Access to resources Recommend Favorite

Probability of prostate cancer as a function of the percentage of free prostate-specific antigen in patients with a non-suspicious rectal examination and total prostate-specific antigen of 4–10 ng/ml

By Martínez-Piñeiro L.  

World Journal of Urology, Vol. 22, Iss. 2, 2004-06 ,pp. : 124-131

Springer Publishing Company

Access to resources Recommend Favorite